The weight loss drug with a waitlist
Sky News has revealed thousands of people with severe obesity are being denied access to effective treatment, partly because of a slow NHS rollout of the weight loss jab Wegovy.
Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Your employer may start covering weight-loss drugs soon
Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, according to a national survey conducted this year by Mercer, a human resources consulting firm.
In Good Health: The obesity rate is falling. What do weight loss drugs have to do with it?
As part of our series In Good Health, we discuss these new medications and the falling rate of obesity.
Health plans at 1 in 5 large companies cover weight-loss drugs for employees
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance plans, a new survey shows.
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the medicine must stop.
Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds for Employees
When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the
Only about 1/5 of large companies cover drugs for weight loss
A survey of employers finds that only about a fifth of large companies cover drugs like Wegovy for weight loss. A majority of companies that do cover the medicines have requirements.
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
Compounding pharmacies are suing the Food and Drug Administration so they can keep making imitation versions of popular—and lucrative—tirzepatide drugs, namely knockoffs of Mounjaro for diabetes and Zepbound for weight loss.
Popular Weight Loss Drugs To Become More Expensive As Shortage Ends
With the shortage over, compounding pharmacies are no longer allowed to produce the popular weight loss drugs.
Amgen Stock Falls. The Obesity Drug Landscape Is Getting Crowded.
Amgen has a lot riding on an experimental obesity drug that it hopes will rival those of Eli Lilly and Novo Nordisk. But one ...
University of Manchester5h
New study to deepen understanding of a weight loss medication
Health Innovation Manchester and The University of Manchester has today (14 October 2024) announced a groundbreaking ...
STAT3d
As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
France won’t pay for weight loss drug Wegovy. What about other European countries?
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...
Medscape7d
Weight Loss After Anti-Obesity Medications Linked to Reduced Gout Risk
Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout ...
Washingtonians share how they afford pricey weight loss medications
Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...
1 in 10 Americans have tried injectable weight loss medication—These are the cities with the most early adopters
Three cities in Hawaii, Minnesota, and Texas report the highest usage of injectable weight loss medications. Meanwhile, ...